BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q4 2025 | 152.84% |
| Q3 2025 | -2.29% |
| Q2 2025 | 13.90% |
| Q1 2025 | 12.41% |
| Q4 2024 | 10.14% |
| Q3 2024 | 5.78% |
| Q2 2024 | 17.64% |
| Q1 2024 | -0.29% |
| Q4 2023 | 7.19% |
| Q3 2023 | 4.99% |
| Q2 2023 | 20.20% |
| Q1 2023 | -11.95% |
| Q4 2022 | 6.70% |
| Q3 2022 | 10.61% |
| Q2 2022 | 31.40% |
| Q1 2022 | 6.30% |
| Q4 2021 | 15.75% |
| Q3 2021 | -18.62% |
| Q2 2021 | 277.71% |
| Q1 2021 | 233.82% |
| Q4 2020 | -14.01% |
| Q3 2020 | 59.39% |
| Q2 2020 | -39.61% |
| Q1 2020 | -87.20% |
| Q4 2019 | 2014.63% |
| Q3 2019 | 23.56% |
| Q2 2019 | -67.69% |
| Q1 2019 | 65.51% |
| Q4 2018 | 85.17% |
| Q3 2018 | -88.28% |
| Q2 2018 | 219.37% |
| Q1 2018 | 1.99% |
| Q4 2017 | -49.87% |
| Q3 2017 | 143.84% |
| Q2 2017 | -66.35% |
| Q1 2017 | 39.99% |
| Q4 2016 | -14.29% |
| Q3 2016 | 60.08% |
| Q2 2016 | 0.36% |
| Q1 2016 | 3.69% |